Anzeige
Mehr »
Sonntag, 05.10.2025 - Börsentäglich über 12.000 News
Innocan Pharma: Neues Medikament für den Massenmarkt?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
240 Leser
Artikel bewerten:
(1)

Harris Data Integrity Solutions White Paper Explores Healthcare's $6 Billion Patient Matching Problem

NIAGARA FALLS, NY / ACCESSWIRE / May 10, 2023 / Harris Data Integrity Solutions, the leading provider of best-in-class patient data integrity services and software, has released a white paper that undertakes an in-depth examination of the healthcare industry's chronic people matching problem. In addition to dissecting the challenges and impacts patient misidentification has on care safety, outcomes, and costs, People Matching in Healthcare: Challenges, Impact and Solutions explores efforts underway on multiple levels to identify a system-wide resolution to the problem.

"The tumultuous state of patient matching exposes patients to duplicative and unnecessary testing and services and care delays, exacerbates fraud risks, impacts public health emergency response, and costs the U.S. healthcare system over $6 billion annually in denied claims," said Lora Hefton, executive vice president of Harris Data Integrity Solutions. "But the future is not as grim as the present might indicate, as our research also found that efforts to identify the right path forward are finding a foothold as stakeholders from across the healthcare continuum come together to remove obstacles and implement effective solutions."

In People Matching in Healthcare: Challenges, Impact and Solutions, Harris Data Integrity Solutions' patient identity experts highlight the efforts of Patient ID Now to eliminate legislative barriers hindering exploration of a unique patient identifier, and the collaborative's work to establish the framework of a national strategy for effective patient identification and matching. They also look at the work undertaken by the Project US@ collaboration, spearheaded by the Office for the National Coordinator (ONC), that resulted in a technical specification for collection of patient addresses, and AHIMA for its related companion guide with operational guidance and best practices.

The white paper also explores the important role the right technology plays in eliminating the patient matching problem at the organizational level - a problem that has helped drive the average duplicate record rate to 18%. The ideal technology solution enables protection across the entire master patient index (MPI) and electronic MPI (EMPI) by operating in multiple environments and at multiple stages throughout the patient record process.

"What is needed is an end-to-end protection model centered on technology capable of catching mismatches and errors upfront and identifying and resolving duplicate and overlaid records, eliminating rather than adding to the patient identification problem," said Hefton. "People Matching in Healthcare describes what that model looks like and provides insights into why the typical EHR system is incapable of addressing the mismatch issue on its own."

People Matching in Healthcare: Challenges, Impact and Solutions is available for download here.

About Harris Data Integrity Solutions
Harris Data Integrity Solutions delivers industry-leading data integrity services and software to reduce duplicate medical records and minimize the ongoing cost of maintaining quality patient data. Created by the integration of two data integrity powerhouses, Just Associates, Inc. and QuadraMed® Corporation, Harris Data Integrity Solutions offers the unparalleled depth and breadth of industry expertise and the commitment to ongoing innovation necessary to meet the changing needs of patients and healthcare organizations. Designed to address the broad spectrum of challenges associated with patient matching and data integrity, its suite of advanced technology solutions and services includes CuraMatch automated duplicate resolution, SmartIX Enterprise Master Patient Index (EMPI) and MPI Clean-up Services. For more information, visit www.harrisdataintegritysolutions.com.

Media Contact:

Liz Goar
NPC Creative Services
liz@npccs.com

SOURCE: Harris Data Integrity Solutions

View source version on accesswire.com:
https://www.accesswire.com/753811/Harris-Data-Integrity-Solutions-White-Paper-Explores-Healthcares-6-Billion-Patient-Matching-Problem

© 2023 ACCESS Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.